Cross Country Healthcare (NASDAQ: CCRN) reported Q1 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $210.3 million versus the consensus estimate of $206.9 million.

GUIDANCE:

Cross Country Healthcare sees Q2 2018 EPS of $0.04-$0.06, versus the consensus of $0.12. Cross Country Healthcare sees Q2 2018 revenue of $206-211 million, versus the consensus of $214.6 million.

For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.